
403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Chinese researchers team identify new bat-to-human coronavirus
(MENAFN) A research team in China has identified a new bat coronavirus that shares the same receptor as Covid-19, enabling it to infect humans. This discovery underscores the need for ongoing monitoring to prevent further spread, as reported by Reuters. The virus belongs to a separate lineage of the HKU5 coronavirus, first found in the Japanese Pipistrelle bat in Hong Kong.
The study was led by Shi Zhengli, known as "batwoman" for her extensive research on bat coronaviruses. Zhengli is also known for her work at the Wuhan Institute of Virology, which has been a focal point in the debate over the origins of Covid-19. Although the lab-leak theory has circulated, Zhengli has denied any connection between the outbreak and the institute.
The new findings come amid ongoing investigations into the origins of Covid-19, with a recent US Congressional report suggesting cover-ups by the Chinese government. Since its emergence in Wuhan in December 2019, the virus has caused millions of deaths worldwide.
The study was led by Shi Zhengli, known as "batwoman" for her extensive research on bat coronaviruses. Zhengli is also known for her work at the Wuhan Institute of Virology, which has been a focal point in the debate over the origins of Covid-19. Although the lab-leak theory has circulated, Zhengli has denied any connection between the outbreak and the institute.
The new findings come amid ongoing investigations into the origins of Covid-19, with a recent US Congressional report suggesting cover-ups by the Chinese government. Since its emergence in Wuhan in December 2019, the virus has caused millions of deaths worldwide.

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment